Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)

NCT00822094

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
View all 42 locations
View Trial Details
Completed

Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

NCT02103335

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • University of Maryland Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Center Detroit, Michigan, United States
View Trial Details
Completed

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

NCT02301364

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions